In the COVID-19 pandemic, antipyretic and analgesic drugs played an important role as an indispensable basic guarantee drug. China has the largest production, marketing and application market of antipyretic and analgesic APIs, and with the upgrading of technology and changes in market demand, the upstream and downstream industrial ecological relationship in the global non-steroidal anti-inflammatory field is becoming increasingly close. Among them, ethyl trifluoroacetate produced by Wanxingda is an important raw material for antipyretic and analgesic Celecoxib and COVID-19 drug Paxlovid, which attracted customers to stop and communicate at the booth.